The experimental study on the radioimmunotherapy of the nasopharyngeal carcinoma overexpressing HER2/neu in nude mice model with intratumoral injection of 188Re-herceptin

Nuclear Medicine and Biology

Volumn 32, Issue 1, 2005, Pages 59-65

  Li, Guiping ^a,b   Wang, Yongxian ^a   Huang, Kai ^b   Zhang, Hui ^b   Peng, Wuhe ^b   Zhang, Chunfu ^a  

^a SHANGHAI INSTITUTE OF APPLIED PHYSICS   (China)

^b FIRST MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Herceptin; Nasopharyngeal carcinoma; Radioimmunotherapy; Rhenium 188

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MONOCLONAL ANTIBODY; RHENIUM 188; TRASTUZUMAB; TRASTUZUMAB RE 188; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PROTEIN EXPRESSION; PROTO ONCOGENE; RADIOACTIVITY; RADIOIMMUNOTHERAPY; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; ANTIBODIES, MONOCLONAL; BODY BURDEN; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; INJECTIONS, INTRALESIONAL; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED BALB C; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; ORGAN SPECIFICITY; RADIOIMMUNOTHERAPY; RADIOISOTOPES; RADIOMETRY; RADIOPHARMACEUTICALS; RECEPTOR, ERBB-2; RELATIVE BIOLOGICAL EFFECTIVENESS; RHENIUM; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

EID: 13244260885     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2004.09.003     Document Type: Article

References (28)

1. N.E. Hynes, and D.F. Stern The biology of erb-B-2/neu/HER-2 and its role in cancer Biochim. Biophys. Acta 1198 1994 165 184
2. 131I-labeled counterparts Cancer Biother. Radiopharm. 11 1996 133 144
3. K. Gu, Q. Wu, J. Hou, B. Wang, and Z. Guang HER-2/neu expression and clinical significance in patients with nasopharyngeal carcinoma Chin. J. Cancer 20 2001 869 872
4. K. Mokbel, and D. Hassanally From HER2 to herceptin Curr. Med. Res. Opin. 17 2001 51 59
5. D.F. Roychowdhury, A. Tseng, K.K. Fu, V. Weinburg, and N. Weidner New prognostic factors in nasopharyngeal carcinoma: tumor angiogenesis and C-erbB-2 expression Cancer 77 1996 1419 1426
6. A.P. Callahan, D.E. Rice, and F.F. Knapp Rhenium-188 for therapeutic applications from an alumina-based tungsten-188/rhenium-188 radionuclide generator Nuc. Compact Eur. Am. Commun. Nucl. Med. 20 1989 3 6
7. 186Re-radioimmunotherapy for treatment in an adjuvant setting of colon cancer J. Cancer Res. Clin. Oncol. 129 2003 392 396
8. 188Re-direct labeling of monoclonal antibodies for radioimmunotherapy of solid tumors: biodistribution, normal organ dosimetry, and toxicology Nucl. Med. Biol. 25 1998 441 447
9. G.L. Griffiths, D.M. Goldenberg, F.F. Knapp, A.P. Callahan, C.H. Chang, and H.J. Hansen Direct radiolabeling of monoclonal antibodies with generator-produced rhenium-188 for radioimmunotherapy: labeling and animal biodistribution studies Cancer Res. 51 1991 4594 4602
10. T. Lindmo, E. Boven, R. Cuttitta, J. Fedorko, and P.A. Bunn Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess J. Immunol. Methods 72 1984 77 89
11. A.B. Delaloye, and B. Delaloye Tumor imaging with monoclonal antibodies Semin. Nucl. Med. 25 1995 144 164
12. S.C. Srivastava Criteria for the selection of radionuclides for targeting nuclear antigens for cancer radioimmunotherapy Cancer Biother. Radiopharm. 11 1996 43 50
13. K. De Santes, D. Slamon, S.K. Anderson, M. Shepard, B. Fendly, and D. Maneval Radiolabeled antibody targeting of the HER-2/neu oncoprotein Cancer Res. 52 1992 1916 1923
14. H. Yazici, M. Altun, C. Alatli, O. Dogan, and N. Dalay c-erbB-2 gene amplification in nasopharyngeal carcinoma Cancer Invest. 18 2000 6 10
15. H.M. Vriesendorp, S.M. Quadri, R.L. Stinson, O. Onyekwere, C.Y. Shao, and J.L. Klein Selection of reagents for human radioimmunotherapy Int. J. Radiat. Oncol. Biol. Phys. 22 1992 37 45
16. T.A. Waldmann, J.D. White, J.A. Carrasquillo, J.C. Reynolds, C.H. Paik, and O.A. Gansow Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with yttrium-90-labeled anti-Tac Blood 86 1995 4063 4075
17. O.C. Boerman, F.G. van Schaijk, W.J.G. Oyen, and F.H.M. Corstens Pretargeted radioimmunotherapy of cancer: progress step by step J. Nucl. Med. 44 2003 400 411
18. D.A. Godwin Pharmacokinetics and antibodies J. Nucl. Med. 28 1987 1358 1362
19. D.W. Parkin, P. Pisani, and J. Ferlay Estimates of the worldwide incidence of 25 major cancers in 1990 Int. J. Cancer 80 1999 827 841
20. J. Okita, C. Hatta, T. Terada, N. Saeki, H. Ogasawara, and M. Kakibuchi Concurrent chemoradiotherapy for nasopharyngeal carcinoma Auris Nasus Larynx 31 2004 43 47
21. M.A. Bakir, S.A. Eccles, J.W. Babich, N. Aftab, J.M. Styles, and C.J. Dean c-erbB2 protein overexpression in breast cancer as a target for PET using iodine-124-labeled monoclonal antibodies J. Nucl. Med. 33 1992 2154 2160
22. E. Horak, F. Hartmann, K. Garmestani, C. Wu, M. Brechbiel, and O.A. Gansow Radioimmunotherapy targeting of HER2/neu oncoprotein on ovarian tumor using lead-212-DOTA-AE1 J. Nucl. Med. 38 1997 1944 1950
23. T.M. Behr, T. Liersch, L. Greiner-Bechert, F. Griesinger, M. Behe, and P.M. Markus Radioimmunotherapy of small-volume disease of metastatic colorectal cancer: results of a phase II trial with the iodine-131-labeled humanized anti-carcinoembryonic antigen antibody hMN-14 Cancer 94 Suppl. 2002 1373 1381
24. D.M. Goldenberg Introduction Cancer 94 Suppl. 2002 1193S 1195S
25. A.B. Delaloye, and B. Delaloye Radiolabelled monoclonal antibodies in tumour imaging and therapy: out of fashion? Eur. J. Nucl. Med. 22 1995 571 580
26. C. Grana, M. Chinol, C. Robertson, C. Mazzetta, M. Bartolomei, and C. De Cicco Pretargeted adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients: a pilot study Br. J. Cancer 86 2002 207 212
27. G. Paganelli, M. Malcoviti, and F. Fazio Monoclonal antibody pretargeting techniques for tumor localization: the avidin-biotin system Nucl. Med. Commun. 12 1991 211 234
28. M. Rusckowski, M. Fogarasi, B. Fritz, and D.J. Hnatowich Effect of endogenous biotin on the applications of streptavidin and biotin in mice Nucl. Med. Biol. 24 1997 263 268